MYELOMA MULTIPLE

This study is testing whether adding a newer drug called belantamab mafodotin to standard lenalidomide maintenance therapy can better eliminate remaining cancer cells in patients with multiple myeloma who have recently received a stem cell transplant. The goal is to help patients…

This early-stage study is testing a new oral medication called KTX-1001 in adults with multiple myeloma that has returned or stopped responding to standard treatments. The main goals are to find the safest and most effective dose and to see how well the body handles the drug. Res…

This early-stage trial is testing the safety of a new gene therapy called KLN-1010 for people with multiple myeloma that has returned or stopped responding to other treatments. The therapy works by modifying the patient's own immune cells inside the body to better target cancer c…

This study is testing whether patients with relapsed multiple myeloma who respond well to teclistamab can safely stop taking the drug for a period, instead of continuing it indefinitely. The goal is to see if taking a break from treatment works as well as continuous therapy while…

This study is testing whether patients with multiple myeloma can safely give themselves their standard chemotherapy injections at home instead of traveling to a hospital. Researchers want to see if home administration works well, is safe, and improves quality of life for patients…

This study is testing whether a smart scale that patients use at home can help doctors remotely monitor adults with lymphoma or myeloma who are getting chemotherapy. For about 7 weeks, 30 patients will weigh themselves daily. The scale sends data to the medical team, who can get …

This small pilot study is testing whether two different emotional support programs are practical and acceptable for people recently diagnosed with advanced cancer. The programs use techniques like cognitive behavioral therapy, hypnosis, and positive psychology to help patients be…

This study aims to better understand various blood cancers by analyzing patient samples using multiple advanced laboratory techniques. Researchers will examine bone marrow, blood, and tissue samples from 1,040 patients across Italy, both from past collections and new participants…

This study is collecting information about how patients with blood cancers and disorders respond to stem cell transplants in the high-altitude Tibetan region. Researchers are enrolling 1000 patients and their donors to track treatment patterns, recovery times, survival rates, and…